Zhenyu Xu

CIK: 0002006362

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)26 (89.7%)

Position reduction

Option Exercises (M)2 (6.9%)

Derivative conversions

Awards (A)1 (3.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SOPH

SOPHiA GENETICS SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (29 total)

SOPH
SOPHiA GENETICS SA
Oct 13, 2026
Sale(S)
Direct
4K shares at avg. $7.18$29K
SOPH
SOPHiA GENETICS SA
Oct 5, 2026
Sale(S)
Direct
7.4K shares at avg. $8.12$60K
SOPH
SOPHiA GENETICS SA
Sep 14, 2026
Sale(S)
Direct
4K shares at avg. $7.88$32K
SOPH
SOPHiA GENETICS SA
Aug 21, 2026
Sale(S)
Direct
5.4K shares at avg. $8.40$45K
SOPH
SOPHiA GENETICS SA
Aug 20, 2026
Sale(S)
Direct
4.6K shares at avg. $8.41$39K
SOPH
SOPHiA GENETICS SA
Aug 19, 2026
Sale(S)
Direct
10K shares at avg. $7.94$79K
SOPH
SOPHiA GENETICS SA
Aug 13, 2026
Sale(S)
Direct
4K shares at avg. $7.52$30K
SOPH
SOPHiA GENETICS SA
Aug 7, 2026
Sale(S)
Direct
10K shares at avg. $7.48$75K
SOPH
SOPHiA GENETICS SA
Aug 7, 2026
Sale(S)
Direct
7K shares at avg. $7.02$49K
SOPH
SOPHiA GENETICS SA
Aug 7, 2026
Exercise(M)
Direct
7K shares at avg. $3.28$23K
SOPH
SOPHiA GENETICS SA
Aug 5, 2026
Exercise(M)
Direct
3K shares at avg. $3.28$10K
SOPH
SOPHiA GENETICS SA
Aug 5, 2026
Sale(S)
Direct
3K shares at avg. $7.00$21K
SOPH
SOPHiA GENETICS SA
Aug 4, 2026
Sale(S)
Direct
10K shares at avg. $6.92$69K
SOPH
SOPHiA GENETICS SA
Jul 13, 2026
Sale(S)
Direct
4K shares at avg. $5.70$23K
SOPH
SOPHiA GENETICS SA
Jul 6, 2026
Sale(S)
Direct
7.4K shares at avg. $5.17$38K
SOPH
SOPHiA GENETICS SA
Jun 15, 2026
Sale(S)
Direct
4K shares at avg. $5.01$20K
SOPH
SOPHiA GENETICS SA
May 19, 2026
Sale(S)
Direct
608 shares at avg. $4.60$3K
SOPH
SOPHiA GENETICS SA
May 13, 2026
Sale(S)
Direct
4K shares at avg. $4.54$18K
SOPH
SOPHiA GENETICS SA
Apr 20, 2026
Sale(S)
Direct
608 shares at avg. $5.21$3K
SOPH
SOPHiA GENETICS SA
Apr 14, 2026
Sale(S)
Direct
600 shares at avg. $4.97$3K
SOPH
SOPHiA GENETICS SA
Apr 13, 2026
Sale(S)
Direct
3.4K shares at avg. $4.76$16K
SOPH
SOPHiA GENETICS SA
Apr 13, 2026
Sale(S)
Direct
1K shares at avg. $4.76$5K
SOPH
SOPHiA GENETICS SA
Apr 10, 2026
Sale(S)
Direct
3.7K shares at avg. $4.68$17K
SOPH
SOPHiA GENETICS SA
Apr 9, 2026
Sale(S)
Direct
1.9K shares at avg. $4.74$9K
SOPH
SOPHiA GENETICS SA
Apr 8, 2026
Sale(S)
Direct
2.8K shares at avg. $4.84$14K

		Type	Shares	Price		Ownership
Oct 13, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	4,000	$7.18	$28,727	Direct
Oct 5, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	7,394	$8.12	$60,075	Direct
Sep 14, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	4,000	$7.88	$31,538	Direct
Aug 21, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	5,408	$8.40	$45,447	Direct
Aug 20, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	4,592	$8.41	$38,609	Direct
Aug 19, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	10,000	$7.94	$79,427	Direct
Aug 13, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	4,000	$7.52	$30,076	Direct
Aug 7, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	10,000	$7.48	$74,759	Direct
Aug 7, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	7,000	$7.02	$49,152	Direct
Aug 7, 2026	SOPH SOPHiA GENETICS SA	Exercise(M)	7,000	$3.28	$22,960	Direct
Aug 5, 2026	SOPH SOPHiA GENETICS SA	Exercise(M)	3,000	$3.28	$9,840	Direct
Aug 5, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	3,000	$7.00	$21,013	Direct
Aug 4, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	10,000	$6.92	$69,168	Direct
Jul 13, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	4,000	$5.70	$22,819	Direct
Jul 6, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	7,393	$5.17	$38,242	Direct
Jun 15, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	4,000	$5.01	$20,056	Direct
May 19, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	608	$4.60	$2,798	Direct
May 13, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	4,000	$4.54	$18,168	Direct
Apr 20, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	608	$5.21	$3,165	Direct
Apr 14, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	600	$4.97	$2,980	Direct
Apr 13, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	3,400	$4.76	$16,197	Direct
Apr 13, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,014	$4.76	$4,830	Direct
Apr 10, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	3,706	$4.68	$17,347	Direct
Apr 9, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	1,936	$4.74	$9,176	Direct
Apr 8, 2026	SOPH SOPHiA GENETICS SA	Sale(S)	2,800	$4.84	$13,549	Direct

1-25 of 29 transactions

About Xu Zhenyu

Xu Zhenyu (SEC CIK 0002006362) files insider reports with the SEC as Chief Scientific Officer of SOPHiA GENETICS SA (SOPH).

Signal8 holds 21 ownership filings by Xu Zhenyu (1 Form 3, 20 Form 4), filed between Mar 18, 2026 and Oct 14, 2026. Those filings report 29 transactions, from Mar 19, 2026 to Oct 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Xu Zhenyu's filings is in ROLLE.

Recent filings by Xu Zhenyu

Oct 13, 2026: Open-market sale of SOPH shares (Form 4, code S).
Oct 5, 2026: Open-market sale of SOPH shares (Form 4, code S).
Sep 14, 2026: Open-market sale of SOPH shares (Form 4, code S).
Aug 21, 2026: Open-market sale of SOPH shares (Form 4, code S).
Aug 20, 2026: Open-market sale of SOPH shares (Form 4, code S).

Other insiders filing for SOPHiA GENETICS SA (SOPH)

Menu Philippe, Chief Medical Officer
Camblong Jurgi, Executive Chairman
Van Well Daan, Chief Legal Officer
Valente Manuela, Chief People Officer
Verma Abhimanyu, Chief Technology Officer
Puylaert Kevin, Chief Sales Officer

How to read Form 4 transaction codes